Literature DB >> 26044001

A miniaturized blotting system for simultaneous detection of different autoantibodies.

Ulrich Canzler1, Holger Bartsch, Kai Großmann, Werner Lehmann, Karsten Conrad, Biji T Kurien, Yaser Dorri, R Hal Scofield, Michael P Bachmann.   

Abstract

Sera of tumor patients frequently contain autoantibodies to tumor associated antigens. Here we describe a miniaturized immunoblot platform allowing us to screen sera of patients for the presence of autoantibodies to ten autoantigens in parallel.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26044001      PMCID： PMC7304527          DOI： 10.1007/978-1-4939-2694-7_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  9 in total

1.  Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis.

Authors:  E M Tan
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

Review 2.  Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology.

Authors:  E M Tan
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

3.  A miniaturized blotting system for simultaneous detecting of different autoantibodies.

Authors:  Ulrich Canzler; Holger Bartsch; Kai Grossmann; Werner Lehmann; Karsten Conrad; Biji T Kurien; Yaser Dorri; R Hal Scofield; Michael Bachmann
Journal:  Methods Mol Biol       Date:  2009

Review 4.  Immunity to oncogenic proteins.

Authors:  M A Cheever; M L Disis; H Bernhard; J R Gralow; S L Hand; E S Huseby; H L Qin; M Takahashi; W Chen
Journal:  Immunol Rev       Date:  1995-06       Impact factor: 12.988

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens.

Authors:  Jian-Ying Zhang; Carlos A Casiano; Xuan-Xian Peng; James A Koziol; Edward K L Chan; Eng M Tan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-02       Impact factor: 4.254

Review 7.  p53 Antibodies in the sera of patients with various types of cancer: a review.

Authors:  T Soussi
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

8.  Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum.

Authors:  Stefania Forti; Matthew J Scanlan; Annamaria Invernizzi; Fabio Castiglioni; Sandro Pupa; Roberto Agresti; Rosanna Fontanelli; Daniele Morelli; Lloyd J Old; Serenella M Pupa; Sylvie Ménard
Journal:  Breast Cancer Res Treat       Date:  2002-06       Impact factor: 4.872

9.  A survey of the humoral immune response of cancer patients to a panel of human tumor antigens.

Authors:  E Stockert; E Jäger; Y T Chen; M J Scanlan; I Gout; J Karbach; M Arand; A Knuth; L J Old
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.